Spolia Therapeutics Revenue
Biotechnology Research • 
Cambridge, Massachusetts, United States • 1-10 Employees
$
Spolia Therapeutics revenue & valuation
| Annual revenue | $684,440 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,200,000 |
| Total funding | No funding |
Key Contacts at Spolia Therapeutics
Mark Tebbe
Chief Technology Officer
Steven Robinette
Chief Executive Officer
Robert Plasschaert
Senior Director Of Biology
Monica Markham
Director Of Operations
Company overview
| Headquarters | Cambridge, Massachusetts, United States |
| NAICS | 541714 |
| Employees | 1-10 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Director
Vice President
Employees by Department
Spolia Therapeutics has 4 employees across 4 departments.
Departments
Number of employees
Funding Data
Spolia Therapeutics has never raised funding before.
United Kingdom
Frequently asked questions
Spolia Therapeutics is located in Cambridge, Massachusetts, US.
Spolia Therapeutics generates an estimated annual revenue of $684,440. This revenue figure reflects the company's market position and business performance in its industry.
Spolia Therapeutics has an estimated valuation of $2,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Spolia Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
